An experimental Boehringer Ingelheim drug achieved “unprecedented” benefits in patients with an advanced form of lung cancer ...

LONDON (AP) — LONDON (AP) — GSK plc (GSK) on Wednesday reported first-quarter earnings of $2.04 billion. The London-based company said it had profit of $1 per share. Earnings, adjusted for one-time ...

British drugmaker GSK said on Wednesday it was "well positioned" to respond to any potential financial impact from ...

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

The report covers 40+ companies and 50+ pipeline drugs. Explore drug profiles from clinical to nonclinical stages, assessment by product type, and detailed pipeline development activities. Key players ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in ...

Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug delivery, and novel pain treatments Recipients include the Children's ...

BNP Paribas Exane analyst Peter Verdult initiated coverage of GSK (GSK) with a Neutral rating and $35.25 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks.

Hence, she liquidated all but a tiny percentage of her GSK holding, dramatically boosting her net gains. Today, we both own small legacy stakes in GSK, but nothing like the lump we once had.

April 15 (Reuters) - British pharmaceutical giant GSK (GSK.L), opens new tab has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara ...